The Peace and Love Hospital has introduced a groundbreaking instrument called CoreView, aimed at significantly improving cancer treatment in Ghana.
Led by Dr. Beatrice Wiafe Addai, the team announced the arrival of this state-of-the-art machine, developed over the past two years in collaboration with two principal investigators from the United States: Professor Richard Levenson of UC Davis and Professor Eric Seibel of the University of Washington.
CoreView enables medical professionals to provide a tissue-based diagnosis to patients within just 10 minutes after a biopsy, allowing for immediate results while the patient remains in the procedure room.
Speaking to journalists following the launch in Kumasi, Dr. Wiafe Addai pointed out the current challenges in obtaining diagnostic images, which often take days, weeks, or even months due to patient transportation and other factors.
With the introduction of CoreView, pathologists can now deliver diagnoses on-site or quickly send digital images to specialists anywhere in the world for analysis.
Peace and Love Hospital is the first facility globally to utilize this technology, equipped with the necessary clearances for such rapid patient care management.
According to the 2022 Global Cancer Statistics (GLOBOCAN) report, Ghana records approximately 27,385 new cases of cancer annually, with an estimated 17,944 deaths attributed to the disease.
Over the past five years, the prevalence of cancer has reached 63,764 cases, with about 16,000 new diagnoses among females, who are disproportionately affected.
Dr. Wiafe Addai noted that CoreView has the potential to significantly reduce cancer-related mortality in Ghana.
Professor Richard Levenson, a health investigator at UC Davis, underscored the importance of the equipment’s real-time capabilities.
He noted that this innovative method is crucial for quickly assessing late-stage cancers, ensuring immediate intervention to prevent further complications or fatalities, as previous diagnostic procedures often took much longer.
Meanwhile, the CoreView imaging process does not interfere with downstream tissue imaging or molecular testing, as standard histology remains available as a gold-standard check on diagnostic quality.
CoreView diagnostics can be performed even in low-resource settings and hard-to-reach areas, making medical care more personal, efficient, and equitable.
